Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    Ruby Khatun Khatun
    Ruby Khatun Khatun
      • Home
      • Ruby Khatun Khatun

      Articles By : Ruby Khatun Khatun

      India threatens Philip Morris with punitive action over alleged violations

      India threatens Philip Morris with punitive action over alleged violations

      Ruby Khatun Khatun20 Aug 2017 9:09 AM IST
      New Delhi: The Indian government has threatened Philip Morris International Inc with "punitive action" over the tobacco giant's alleged violation of...
      Draft pharma policy calls for trade margins cap

      Draft pharma policy calls for trade margins cap

      Ruby Khatun Khatun19 Aug 2017 2:00 PM IST
      New Delhi: The government is mulling fixing trade margins on drugs to bring down costs and create a level-playing field for the pharma...
      Cap prices of drugs and medical appliances also: Doctors body

      Cap prices of drugs and medical appliances also: Doctors body

      Ruby Khatun Khatun19 Aug 2017 10:15 AM IST
      New Delhi: After the government fixed a price range for knee implants, a national body of medics working to promote ethical healthcare has demanded...
      Mylan, US finalise 465 million dollar EpiPen settlement

      Mylan, US finalise 465 million dollar EpiPen settlement

      Ruby Khatun Khatun19 Aug 2017 10:00 AM IST
      BOSTON: Mylan NV has finalised a $465 million settlement resolving U.S. Justice Department claims it overcharged the government for its EpiPen...
      Zydus Cadila gets USFDA approval for hypertension drug

      Zydus Cadila gets USFDA approval for hypertension drug

      Ruby Khatun Khatun19 Aug 2017 10:00 AM IST
      New Delhi: Zydus Cadila has received final approval from the US health regulator to market Telmisartan and hydrochlorothiazide tablets, used in...
      Columbia Clinic by Columbia Asia Hospitals Launched at Embassy TechVillage in Bangalore

      Columbia Clinic by Columbia Asia Hospitals Launched at Embassy TechVillage in Bangalore

      Ruby Khatun Khatun19 Aug 2017 9:45 AM IST
      BENGALURU: Over the last two decades there has been an alarming rise in cardiovascular diseases, diabetes, hypertension, asthma and respiratory...
      Novo Nordisk diabetes drug succeeds in key trial

      Novo Nordisk diabetes drug succeeds in key trial

      Ruby Khatun Khatun19 Aug 2017 9:30 AM IST
      Novo Nordisk A/S said on Wednesday its diabetes drug met the main goal of reducing glucose levels in patients in a key late-stage trial, setting the...
      New pharma policy to restrict power of NPPA to fix prices

      New pharma policy to restrict power of NPPA to fix prices

      Ruby Khatun Khatun18 Aug 2017 5:00 PM IST
      New Delhi: The government has come up with a new draft pharmaceutical policy for prescribing the level of trade margins to bring down the prices of...
      Sun Pharma receives amalgamation order from NCLT

      Sun Pharma receives amalgamation order from NCLT

      Ruby Khatun Khatun18 Aug 2017 10:30 AM IST
      Mumbai: Sun Pharmaceutical Industries (Sun Pharma) has received the order passed by National Company Law Tribunal (NCLT) at Ahmedabad bench in the...
      FDA approves Pfizers drug for rare blood cancer

      FDA approves Pfizers drug for rare blood cancer

      Ruby Khatun Khatun18 Aug 2017 10:15 AM IST
      The U.S. Food and Drug Administration (FDA) said on Thursday it approved Pfizer Inc's rare blood cancer drug, Besponsa, with a boxed warning.Besponsa...
      Granules India revenue increases by 10 percent to Rs 386 Crore

      Granules India revenue increases by 10 percent to Rs 386 Crore

      Ruby Khatun Khatun18 Aug 2017 9:45 AM IST
      HYDERABAD: Granules India Ltd., a growing pharmaceutical manufacturing company, announced financial results for its first quarter ended 30th June,...
      USFDA issues EIR for Granules Indias Gagillapur plant

      USFDA issues EIR for Granules Indias Gagillapur plant

      Ruby Khatun Khatun17 Aug 2017 12:09 PM IST
      New Delhi: Drug firm Granules India on Wednesday said the US health regulator has issued establishment inspection report for its Gagillapur plant in...
      PrevNext

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok